Font Size: a A A
Keyword [T790M mutation]
Result: 21 - 39 | Page: 2 of 2
21. A Preclinical Study Of Osimertinib(AZD9291) Combined With Radiation For EGFR T790M Mutant Nonsmall Cell Lung Cancer
22. The Research Of Inhibitory Effect Of EGFR Tyrosine Kinase Inhibitor On Lung Cancer Cells
23. Clinical Characteristics Of Advanced Lung Adenocarcinoma Patients With T790M Mutation After A Failure Of First-and Second-generation EGFR-TKIs Treatment
24. The Association Between BIM Deletion Polymorphism And Therapeutic Efficacy In Advanced EGFR T790M NSCLC With Osimertinib
25. Design,Synthesis And Anticancer Activity Studies Of AZD9291 Derivatives Overcoming T790M/L858R Drug Resistance Mutation
26. Correlation Between Clinical Features Of Patients With Advanced NSCLC After The First Generation EGFR-TKIS Resistance And T790M Mutation,the Efficacy Of Osimertinib
27. The Efficacy And Safety Of Patients With EGFR-T790M Mutation-positive Advanced Non-small Cell Lung Cancer With Different Sources Osimertinib Treatment
28. Analysis Of EGFR T790M Mutation Rate And Related Characteristics After First-line Treatment Of Advanced Non-small Cell Lung Cancer With Sensitive Mutations
29. The Effect Of EGFR Gene Mutation Status On The Clinical Outcomes Of Patients With Non-small Cell Lung Cancer
30. Clinical Outcome And Resistance Mechanism Of Osimertinib In EGFR-mutated Advanced Non-Small-Cell Lung Cancer
31. Clinical Application Of Plasma DdPCR Detection Of EGFR 20Exon T790M Mutation In NSCLC
32. To Explore The Appropriate Population Of Advanced EGFR-mutant Non-small Cell Lung Cancer Treated With The First-or Second-followed By Third-generation EGFR-TKI
33. Correlation Between CT Signs,Tumor Markers And T790M Mutation After EGFR-TKIs Failure In Advanced Lung Adenocarcinoma
34. Analysis Of Clinical Characteristics Of Advanced Lung Adenocarcinoma Patients With Acquired T790M Mutation In The Epidermal Growth Factor Receptor
35. Observation On The Efficacy Of Osimertinib Combined With Anti-angiogenic Drugs In Advanced NSCLC Patients With T790M Mutation After First-generation EGFR-TKIs Resistance
36. Correlation Analysis Of Acquired EGFR T790M Mutation In Advanced Lung Adenocarcinoma
37. Correlation Analysis Of EGFR-TKIs Treatment Prognosis And T790M Mutation Status In Patients With Lung Cancer
38. The Clinical Characteristics And Prognosis Of Patients With Different T790M Mutation States After EGFR-TKI Resistance In Advanced Lung Adenocarcinoma
39. Design,Synthesis And Structure-activity Relationship Study Of Dihydroquinoxalinone EGFRT790M Inhibitors
  <<First  <Prev  Next>  Last>>  Jump to